Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe
Home
Issues
2022
May 2022 - Vol 15 No 3
March 2022 - Vol 15 No 2
January 2022 - Vol 15 No 1 – Online Only
2021
November 2021 - Vol 14 No 7
October 2021 - Vol 14 No 6 | Biosimilars
September 2021 - Vol 14 No 5
July 2021 - Vol 14 No 4
May 2021 - Vol 14 No 3
March 2021 - Vol 14 No 2
January 2021 - Vol 14 No 1
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
Issue Archive
Special Issues
Supplements
ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
Checkmate 9LA
Checkmate 227
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2021 Wrap-Up - Breast Cancer
Web Exclusives
Ovarian Cancer Overview
Interview with the Innovators
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
William King
Authored Items
Updated NCCN Guidelines Lower Age for Initial Colorectal Cancer Screening
William King
TOP - May 2022 Vol 15, No 3
in
NCCN 2022 Highlights
Pembrolizumab Added to Best Supportive Care Extends Survival in Patients with Hepatocellular Carcinoma
William King
TOP - May 2022 Vol 15, No 3
in
ASCO GI 2022 Highlights
Nivolumab plus Ipilimumab Yields High Rate of pCR in the Neoadjuvant Setting for Patients with Resectable MSI/dMMR Oeso-Gastric Adenocarcinoma
William King
TOP - May 2022 Vol 15, No 3
in
ASCO GI 2022 Highlights
Trastuzumab Deruxtecan Shows Survival Benefit in HER2-Positive Advanced Gastric Cancers
William King
TOP - May 2022 Vol 15, No 3
in
ASCO GI 2022 Highlights
Continuous Treatment with Enzalutamide and Docetaxel Reduces the Risk for Progression in Patients with Metastatic Castration-Resistant Prostate Cancer
William King
TOP - May 2022 Vol 15, No 3
in
ASCO GU 2022 Highlights
Neoadjuvant Enfortumab Vedotin Therapy Promising in Patients with Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
William King
TOP - May 2022 Vol 15, No 3
in
ASCO GU 2022 Highlights
New Treatment Strategies for Patients with Advanced Melanoma
William King
TOP - May 2022 Vol 15, No 3
in
NCCN 2022 Highlights
The Future of Genetic Therapies and Value-Based Care in Oncology
William King
TOP - May 2022 Vol 15, No 3
in
AVBCC Summit Highlights
Community Provider Perspective: The Current and Future State of Cancer Care
William King
TOP - May 2022 Vol 15, No 3
in
AVBCC Summit Highlights
Biosimilars and the Road Ahead: Experts Discuss Opportunities and Challenges
William King
TOP - March 2022 Vol 15, No 2
in
AVBCC Summit Highlights
Novel Immunotherapy Combination Appears Effective in Patients with Metastatic Pancreatic Cancer
William King
TOP - March 2022 Vol 15, No 2
in
ASCO
Mosunetuzumab Induces Deep Remissions in Patients with Relapsed/Refractory Follicular Lymphoma
William King
TOP - January 2022 Vol 15, No 1 – Online Only
in
ASH
The Current and Future State of Medically Integrated Pharmacy in Oncology
William King
TOP - January 2022 Vol 15, No 1 – Online Only
in
AVBCC Summit Highlights
Experts Agree That Flexibility and Adaptability Are Essential for Future-Proofing Cancer Care Against Pandemics
William King
TOP - January 2022 Vol 15, No 1 – Online Only
in
AVBCC Summit Highlights
Value-Based Contracting in Oncology: AVBCC Panel Focuses on Strategies to Improve Patient Care
William King
TOP - January 2022 Vol 15, No 1 – Online Only
in
AVBCC Summit Highlights
Results from 2 Studies Provide Insights on Antibody Response to COVID-19 Vaccines in Patients with Hematologic Malignancies
William King
TOP - January 2022 Vol 15, No 1 – Online Only
in
ASH
CAR T-Cell Therapies Show Efficacy in Second-Line Treatment of Large B-Cell Lymphoma
William King
TOP - January 2022 Vol 15, No 1 – Online Only
in
ASH
Results from CAPTURE Trial Support Third COVID-19 Vaccine Dose for Some Patients with Cancer
William King
TOP - November 2021 Vol 14, No 7
in
COVID-19 & Cancer
New Saliva Test Accurately Detects HPV-Associated Head and Neck Cancer
William King
TOP - November 2021 Vol 14, No 7
in
Head and Neck Cancer
Olaparib Extends Disease-Free Survival in Patients with Early-Stage Breast Cancer and BRCA Mutation
William King
TOP - November 2021 Vol 14, No 7
in
Breast Cancer
5-Year Follow-Up Study Confirms Safety and Efficacy of Trastuzumab Biosimilar in Patients with HER2-Positive Breast Cancer
William King
TOP - October 2021 Vol 14, No 6 | Biosimilars
in
ESMO
Zanidatamab Demonstrates Durable Antitumor Activity in HER2-Overexpressing Gastric Cancers
William King
TOP - May 2021 Vol 14, No 3
in
Gastrointestinal Cancers
Ivosidenib Extends Survival in Patients with Cholangiocarcinoma and IDH1 Mutation
William King
TOP - May 2021 Vol 14, No 3
in
Cholangiocarcinoma
Belantamab Induces Clinically Meaningful Responses in Heavily Pretreated Patients with Multiple Myeloma
William King
TOP - March 2021 Vol 14, No 2
in
ASH 2020 Highlights
Umbralisib plus Ublituximab Regimen Superior to Chemoimmunotherapy in CLL
William King
TOP - March 2021 Vol 14, No 2
in
ASH 2020 Highlights
Pevonedistat plus Azacitidine Combination Shows Encouraging Activity in Higher-Risk MDS
William King
TOP - March 2021 Vol 14, No 2
in
ASH 2020 Highlights
Targeting HIF-2 Has the Potential to Improve Outcomes for Patients with Clear-Cell Renal-Cell Carcinoma
William King
TOP - January 2021 Vol 14, No 1
in
Renal-Cell Carcinoma
Novel Drug Combinations Achieving Undetectable Minimal Residual Disease in Patients with CLL
William King
TOP - January 2021 Vol 14, No 1
in
Hematologic Malignancies
First-Line Combinations Show Promise in the Treatment of Advanced Renal-Cell Carcinoma
William King
TOP - January 2021 Vol 14, No 1
in
Renal-Cell Carcinoma
Strategies for Lowering the Cost of Cancer Care
William King
TOP - November 2020 Vol 13, No 6
in
NCCN
Tumor-Infiltrating Lymphocytes Show Promising Activity in Patients with Advanced Melanoma
William King
TOP - November 2020 Vol 13, No 6
in
Emerging Therapies
AACR’s Cancer Disparities Progress Report Highlights Need for Healthcare Equity
William King
TOP - November 2020 Vol 13, No 6
in
Disparities in Oncology
The Impact of COVID-19 on the Oncology Care Model
William King
TOP - November 2020 Vol 13, No 6
in
NCCN
Experts Agree That Innovation Is Key to Improving Value-Based Care
William King
TOP - November 2020 Vol 13, No 6
in
NCCN
Few Actionable Genomic Alterations Identified in Renal-Cell Carcinoma
William King
TOP - September 2020 Vol 13, No 5
in
Renal-Cell Carcinoma
Capmatinib Shows Promise in MET-Amplified Non–Small-Cell Lung Cancer
William King
TOP - September 2020 Vol 13, No 5
in
Lung Cancer
Pembrolizumab Added to First-Line Chemotherapy Improves Progression-Free Survival in Metastatic TNBC
William King
TOP - September 2020 Vol 13, No 5
in
Breast Cancer
Adavosertib Monotherapy Demonstrates Promising Clinical Activity in Uterine Serous Cancer
William King
TOP - September 2020 Vol 13, No 5
in
Emerging Therapies
,
Gynecologic Cancers
Nivolumab plus Ipilimumab May Be a New First-Line Option for Patients with MSI-H or dMMR Metastatic Colorectal Cancer
William King
TOP - September 2020 Vol 13, No 5
in
Colorectal Cancer
Axicabtagene Ciloleucel Induces Durable Responses in Advanced Follicular Lymphoma and Marginal-Zone Lymphoma
William King
TOP - September 2020 Vol 13, No 5
in
Lymphoma
Adjuvant Treatment with Osimertinib Is Highly Effective in EGFR-Mutated Earlier-Stage NSCLC
William King
TOP - September 2020 Vol 13, No 5
in
Lung Cancer
Last modified: August 17, 2020
Home
Issues
2022
May 2022 - Vol 15 No 3
March 2022 - Vol 15 No 2
January 2022 - Vol 15 No 1 – Online Only
2021
November 2021 - Vol 14 No 7
October 2021 - Vol 14 No 6 | Biosimilars
September 2021 - Vol 14 No 5
July 2021 - Vol 14 No 4
May 2021 - Vol 14 No 3
March 2021 - Vol 14 No 2
January 2021 - Vol 14 No 1
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
Issue Archive
Special Issues
Supplements
ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
Checkmate 9LA
Checkmate 227
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2021 Wrap-Up - Breast Cancer
Web Exclusives
Ovarian Cancer Overview
Interview with the Innovators
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
TOP
Print Edition
We will request your mailing address on the next page.
TOP
E-Newsletters and Communications
JHOP
Print Edition
We will request your mailing address on the next page.
JHOP
E-Newsletters and Communications
I have reviewed and consent to the terms of
TOP
's
Privacy Policy
, and
TOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
